FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

DANIELI ILAN
2. Issuer Name and Ticker or Trading Symbol

Precipio, Inc. [ PRPO ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)          (First)          (Middle)

C/O PRECIPIO, INC., 4 SCIENCE PARK
3. Date of Earliest Transaction (MM/DD/YYYY)

9/3/2019
(Street)

NEW HAVEN, CT 06511
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  9/3/2019    P    965  A $2.58  12865  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
DANIELI ILAN
C/O PRECIPIO, INC.
4 SCIENCE PARK
NEW HAVEN, CT 06511
X
Chief Executive Officer

Signatures
/s/ Danieli Ilan 9/5/2019
**Signature of Reporting Person Date


Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Precipio Charts.
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Precipio Charts.

Precipio, Inc. News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Precipio Announces Year end 2023 Shareholder Update Call
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
Tuesday 13 February 2024 (3 months ago) • GlobeNewswire Inc.
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
Tuesday 6 February 2024 (3 months ago) • GlobeNewswire Inc.
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter
Tuesday 23 January 2024 (3 months ago) • GlobeNewswire Inc.
Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 19 January 2024 (3 months ago) • Edgar (US Regulatory)
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
Wednesday 17 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 2 January 2024 (4 months ago) • Edgar (US Regulatory)
Precipio Announces Christina Valauri joins the Board of Directors
Tuesday 2 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 14 December 2023 (5 months ago) • Edgar (US Regulatory)
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024
Thursday 14 December 2023 (5 months ago) • GlobeNewswire Inc.